Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Rickenbach

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Antiviral Therapy|October 9, 2009
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIVJim Young, Heiner C Bucher, Huldrych F Guenthard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort StudyKatja Wolf, James Young, Martin Rickenbach, et al.
HIV Clinical Trials|May 18, 2007
Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort StudyTracy R Glass, Rainer Weber, Pietro L Vernazza, et al.
Journal of Clinical Epidemiology|December 26, 2008
Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapyJim Young, Tracy R Glass, Enos Bernasconi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2005
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapyGilbert R Kaufmann, Hansjakob Furrer, Bruno Ledergerber, et al.
AIDS (London, England)|November 14, 2009
High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndromeSigne W Worm, Nina Friis-Møller, Mathias Bruyand, et al.
AIDS (London, England)|October 3, 2003
Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survivalCornelia Staehelin, Martin Rickenbach, Nicola Low, et al.
AIDS (London, England)|December 20, 2007
Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology surveySabine Yerly, Viktor von Wyl, Bruno Ledergerber, et al.
BMC Gastroenterology|July 9, 2015
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected personsFlorian Bihl, Gladys Martinetti, Gilles Wandeler, et al.
AIDS Research and Human Retroviruses|October 9, 2010
Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort studyRegina B Osih, Patrick Taffé, Martin Rickenbach, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Antiviral Therapy|October 9, 2009
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIVJim Young, Heiner C Bucher, Huldrych F Guenthard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2003
Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort StudyKatja Wolf, James Young, Martin Rickenbach, et al.
HIV Clinical Trials|May 18, 2007
Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort StudyTracy R Glass, Rainer Weber, Pietro L Vernazza, et al.
Journal of Clinical Epidemiology|December 26, 2008
Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapyJim Young, Tracy R Glass, Enos Bernasconi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2005
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapyGilbert R Kaufmann, Hansjakob Furrer, Bruno Ledergerber, et al.
AIDS (London, England)|November 14, 2009
High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndromeSigne W Worm, Nina Friis-Møller, Mathias Bruyand, et al.
AIDS (London, England)|October 3, 2003
Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survivalCornelia Staehelin, Martin Rickenbach, Nicola Low, et al.
AIDS (London, England)|December 20, 2007
Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology surveySabine Yerly, Viktor von Wyl, Bruno Ledergerber, et al.
BMC Gastroenterology|July 9, 2015
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected personsFlorian Bihl, Gladys Martinetti, Gilles Wandeler, et al.
AIDS Research and Human Retroviruses|October 9, 2010
Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort studyRegina B Osih, Patrick Taffé, Martin Rickenbach, et al.
Pageof 7